Histone demethylase PHF8 in cancer: oncogenic mechanisms and advances in inhibitor development

Abstract Plant homeodomain finger protein 8 (PHF8), a JmjC domain-containing lysine demethylase, serve as a critical epigenetic regulator of tumor progression. By erasing repressive histone methylation marks and modulating non-histone substrates TOPBP1 and YY1, PHF8 remodels oncogenic transcriptional networks to drive core cancer hallmarks, including aberrant proliferation, epithelial-mesenchymal transition (EMT), immune evasion, metabolic reprogramming, and inflammatory microenvironments. Aberrant PH8 upregulation across diverse human cancers consistently correlates with unfavorable clinical outcomes, establishing PHF8 as a promising druggable epigenetic target. This review systematically delineates the structural characteristics, substrates profiles, and multifaceted oncogenic mechanisms of PHF8 in malignancies, ranging from early non-selective JmjC inhibitors (daminozide, GSK-J4, etc. ) to newly identified selective small-molecule antagonist and PHD finger-targeting cyclic peptides represented by OC9. Major drawbacks of existing compounds include insufficient selectivity against homologous KDM7A and incomplete suppression of PHF8 non-catalytic oncogenic roles. We further discuss actionable strategies: structural-guided drug design, natural product optimization, peptide modification and PROTAC-mediated protein degradation. Combinations of PHF8 modulators with clinical drugs are also highlighted to overcome drug resistance. This overview provides a refined framework to facilitate further basic research and translational development of PHF8-targeted anticancer therapeutics.

Authors

Institutions

Publication Details

Journal
Clinical Epigenetics
Published
2026-11-16
DOI
https://doi.org/10.1186/s13148-026-02270-2
Primary Topic
Epigenetics and DNA Methylation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Histone demethylase PHF8 in cancer: oncogenic mechanisms and advances in inhibitor development

Duchuang Wang, Jiayuan Li, Xiaosu Ke, Xiaonan Wu et al.
Clinical Epigenetics
Epigenetics and DNA Methylation
article

Histone demethylase PHF8 in cancer: oncogenic mechanisms and advances in inhibitor development

Duchuang Wang, Jiayuan Li, Xiaosu Ke, Xiaonan Wu, Wen Liu, Yongfu Ning
article en

Abstract

Abstract Plant homeodomain finger protein 8 (PHF8), a JmjC domain-containing lysine demethylase, serve as a critical epigenetic regulator of tumor progression. By erasing repressive histone methylation marks and modulating non-histone substrates TOPBP1 and YY1, PHF8 remodels oncogenic transcriptional networks to drive core cancer hallmarks, including aberrant proliferation, epithelial-mesenchymal transition (EMT), immune evasion, metabolic reprogramming, and inflammatory microenvironments. Aberrant PH8 upregulation across diverse human cancers consistently correlates with unfavorable clinical outcomes, establishing PHF8 as a promising druggable epigenetic target. This review systematically delineates the structural characteristics, substrates profiles, and multifaceted oncogenic mechanisms of PHF8 in malignancies, ranging from early non-selective JmjC inhibitors (daminozide, GSK-J4, etc. ) to newly identified selective small-molecule antagonist and PHD finger-targeting cyclic peptides represented by OC9. Major drawbacks of existing compounds include insufficient selectivity against homologous KDM7A and incomplete suppression of PHF8 non-catalytic oncogenic roles. We further discuss actionable strategies: structural-guided drug design, natural product optimization, peptide modification and PROTAC-mediated protein degradation. Combinations of PHF8 modulators with clinical drugs are also highlighted to overcome drug resistance. This overview provides a refined framework to facilitate further basic research and translational development of PHF8-targeted anticancer therapeutics.

Clinical Epigenetics
Xiamen University (CN), Shanghai Innovative Research Center of Traditional Chinese Medicine (CN), China Academy of Chinese Medical Sciences (CN)
Good health and well-being
Epigenetics and DNA Methylation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon